Cristina Larkin - Net Worth and Insider Trading

Cristina Larkin Net Worth

The estimated net worth of Cristina Larkin is at least $2,130 dollars as of 2024-06-04. Cristina Larkin is the COO of Spero Therapeutics Inc and owns about 1,500 shares of Spero Therapeutics Inc (SPRO) stock worth over $2,130. Details can be seen in Cristina Larkin's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Cristina Larkin has not made any transactions after 2020-12-16 and currently still holds the listed stock(s).

Transaction Summary of Cristina Larkin

To

Cristina Larkin Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Cristina Larkin owns 1 companies in total, including Spero Therapeutics Inc (SPRO) .

Click here to see the complete history of Cristina Larkin’s form 4 insider trades.

Insider Ownership Summary of Cristina Larkin

Ticker Comapny Transaction Date Type of Owner
SPRO Spero Therapeutics Inc 2020-12-16 Chief Operating Officer

Cristina Larkin Latest Holdings Summary

Cristina Larkin currently owns a total of 1 stock. Cristina Larkin owns 1,500 shares of Spero Therapeutics Inc (SPRO) as of December 16, 2020, with a value of $2,130.

Latest Holdings of Cristina Larkin

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
SPRO Spero Therapeutics Inc 2020-12-16 1,500 1.42 2,130

Holding Weightings of Cristina Larkin


Cristina Larkin Form 4 Trading Tracker

According to the SEC Form 4 filings, Cristina Larkin has made a total of 1 transactions in Spero Therapeutics Inc (SPRO) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Spero Therapeutics Inc is the sale of 12,000 shares on December 16, 2020, which brought Cristina Larkin around $228,000.

Insider Trading History of Cristina Larkin

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Cristina Larkin Trading Performance

GuruFocus tracks the stock performance after each of Cristina Larkin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Cristina Larkin is -0.08%. GuruFocus also compares Cristina Larkin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Cristina Larkin within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Cristina Larkin's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Cristina Larkin

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -4.67 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -6.14 LIMIT LIMIT LIMIT LIMIT LIMIT

Cristina Larkin Ownership Network

Ownership Network List of Cristina Larkin

No Data

Ownership Network Relation of Cristina Larkin

Insider Network Chart

Cristina Larkin Owned Company Details

What does Spero Therapeutics Inc do?

Who are the key executives at Spero Therapeutics Inc?

Cristina Larkin is the Chief Operating Officer of Spero Therapeutics Inc. Other key executives at Spero Therapeutics Inc include Chief Financial Officer Sath Shukla , director & See Remarks Ankit Mahadevia , and Chief Medical Officer Kamal Hamed .

Spero Therapeutics Inc (SPRO) Insider Trades Summary

Over the past 18 months, Cristina Larkin made no insider transaction in Spero Therapeutics Inc (SPRO). Other recent insider transactions involving Spero Therapeutics Inc (SPRO) include a net sale of 91,515 shares made by Sath Shukla , a net sale of 85,121 shares made by Ankit Mahadevia , and a net sale of 36,219 shares made by Timothy Keutzer .

In summary, during the past 3 months, insiders sold 0 shares of Spero Therapeutics Inc (SPRO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 316,580 shares of Spero Therapeutics Inc (SPRO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 316,580 shares.

Spero Therapeutics Inc (SPRO)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Spero Therapeutics Inc Insider Transactions

No Available Data

Cristina Larkin Mailing Address

Above is the net worth, insider trading, and ownership report for Cristina Larkin. You might contact Cristina Larkin via mailing address: C/o Spero Therapeutics, Inc., 675 Massachusetts Avenue, 14th Floor, Cambridge Ma 02139.

Discussions on Cristina Larkin

No discussions yet.